David A. Siegel Acrivon Therapeutics, Inc. Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 32,600 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,600Holding current value
$0% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACRV
# of Institutions
54Shares Held
18.5MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA8.34MShares$00.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA2.12MShares$00.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.9MShares$00.0% of portfolio
-
Wellington Management Group LLP Boston, MA888KShares$00.0% of portfolio
-
Black Rock Inc. New York, NY767KShares$00.0% of portfolio